Two-year outcomes of “treat and extend” intravitreal therapy for neovascular age-related macular degeneration Save Sight Registries Two-year outcomes of “treat and extend” intravitreal therapy for neovascular age-related macular degeneration Read More »
Time to initial clinician-reported inactivation of neovascular age-related macular degeneration treated primarily with ranibizumab Save Sight Registries Time to initial clinician-reported inactivation of neovascular age-related macular degeneration treated primarily with ranibizumab Read More »
Outcomes of persistently active neovascular age-related macular degeneration treated with VEGF inhibitors: observational study data Save Sight Registries Outcomes of persistently active neovascular age-related macular degeneration treated with VEGF inhibitors: observational study data Read More »
Consequences of long-term discontinuation of vascular endothelial growth factor inhibitor therapy in the patients with neovascular age-related macular degeneration Save Sight Registries Consequences of long-term discontinuation of vascular endothelial growth factor inhibitor therapy in the patients with neovascular age-related macular degeneration Read More »
Intravitreal therapy in bilateral neovascular age-related macular degeneration Save Sight Registries Intravitreal therapy in bilateral neovascular age-related macular degeneration Read More »
Reasons for discontinuation of intravitreal vascular endothelial growth factor inhibitors in neovascular age-related macular degeneration Save Sight Registries Reasons for discontinuation of intravitreal vascular endothelial growth factor inhibitors in neovascular age-related macular degeneration Read More »
Comparison of outcomes from a phase 3 study of age-related macular degeneration with a matched, observational cohort Save Sight Registries Comparison of outcomes from a phase 3 study of age-related macular degeneration with a matched, observational cohort Read More »
Efficient capture of high-quality data on outcomes of treatment for macular diseases: the fight retinal blindness! Project Save Sight Registries Efficient capture of high-quality data on outcomes of treatment for macular diseases: the fight retinal blindness! Project Read More »
Prospective Audit of Exudative Age-Related Macular Degeneration: 12-Month Outcomes in Treatment-Naïve Eyes Save Sight Registries Prospective Audit of Exudative Age-Related Macular Degeneration: 12-Month Outcomes in Treatment-Naïve Eyes Read More »
